ロード中...
Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial
Background and aims: Ulcerative colitis (UC) is an acute and chronic inflammatory disease of the large bowel with unknown aetiology. The immune response against normal commensal microorganisms is believed to drive inflammatory processes associated with UC. Therefore, modulation of bacterial communit...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Copyright 2005 by Gut
2005
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774839/ https://ncbi.nlm.nih.gov/pubmed/15647189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.044834 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|